GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization (Q83128953)
Jump to navigation
Jump to search
scientific article published on 04 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization |
scientific article published on 04 January 2011 |
Statements
GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization (English)
Cathy J Tralau-Stewart
Richard A Williamson
Anthony T Nials
Michele Gascoigne
John Dawson
Graham J Hart
Anthony D R Angell
Yemisi E Solanke
Fiona S Lucas
Joanne Wiseman
Peter Ward
Lisa E Ranshaw
Richard G Knowles